Want to take quizzes and track your credits?
More than 60 years ago, the US and the USSR, while in the midst of the Cold War, collaborated to produce and scale a new oral polio vaccine and test it on millions of Soviet schoolchildren. The 3 poliovirus strains suitable for vaccine production were first developed in the laboratory of Albert Sabin and were sent (with US government approval) to the USSR, where Sabin then worked with Soviet science counterparts, including Mikhail Chumakov. These studies paved the way for the Global Polio Eradication Initiative. Later, in the 1960s, the USSR refined a technique for freeze-drying the smallpox vaccine, making it possible to deliver it intact to remote tropical areas. This innovation helped D.A. Henderson, a US epidemiologist, to lead a global smallpox eradication campaign under the auspices of the World Health Organization (WHO). In both cases, 2 political enemies put aside their differences to collaborate on solving great public health or pandemic threats.1 Both achievements helped to ignite a modern international framework of vaccine diplomacy for promoting scientific collaboration for vaccine development and ensuring vaccine equity.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Corresponding Authors: Peter J. Hotez, MD, PhD, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030 (email@example.com); K. M. Venkat Narayan, MD,1518 Clifton Rd NE, Atlanta, GA 30322 (firstname.lastname@example.org).
Published Online: May 28, 2021. doi:10.1001/jama.2021.7439
Conflict of Interest Disclosures: Dr Hotez reported being a developer of vaccines against COVID-19 and other coronaviruses as well as neglected tropical diseases, including Chagas disease, hookworm, schistotomiasis, and leishmaniasis, in which the vaccine technology is owned by Baylor College of Medicine and nonexclusively licensed to Biological E, one of India’s big vaccine manufacturers, that are either in development or clinical trials, for which he has not received compensation or remuneration. Dr Narayan was partly supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (award numbers P30DK111024 and 3P30DK111024-05S1).
Disclaimer: The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
You currently have no searches saved.